SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 27 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $74,000 | -9.8% | 100,000 | 0.0% | 0.01% | -25.0% |
| Q3 2019 | $82,000 | +2.5% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $80,000 | 0.0% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $80,000 | -10.1% | 100,000 | -0.5% | 0.01% | -20.0% |
| Q4 2018 | $89,000 | -45.1% | 100,500 | +17.5% | 0.01% | -44.4% |
| Q3 2018 | $162,000 | -3.0% | 85,500 | -14.9% | 0.02% | -5.3% |
| Q2 2018 | $167,000 | -13.0% | 100,500 | +0.5% | 0.02% | -20.8% |
| Q1 2018 | $192,000 | +6.1% | 100,000 | +5.7% | 0.02% | +14.3% |
| Q4 2017 | $181,000 | +503.3% | 94,635 | +278.5% | 0.02% | +320.0% |
| Q3 2017 | $30,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,492,975 | $3,597,974,000 | 1.05% |
| &PARTNERS | 51,961 | $42,000 | 0.06% |
| Glassman Wealth Services | 72,366 | $58,000 | 0.02% |
| Sigma Planning Corp | 385,737 | $309,000 | 0.02% |
| HBK Sorce Advisory LLC | 100,000 | $80,000 | 0.01% |
| Fore Capital, LLC | 56,300 | $45,000 | 0.01% |
| WealthTrust Axiom LLC | 17,320 | $13,000 | 0.01% |
| B. Riley Wealth Management, Inc. | 40,800 | $33,000 | 0.01% |
| Semmax Financial Advisors Inc. | 7,290 | $6,000 | 0.00% |
| Ausdal Financial Partners, Inc. | 10,025 | $9,000 | 0.00% |